Top Headlines in Breast Cancer: diagnoses increase post-pandemic; hair products increase breast cancer risk; and more
In this edition, late-stage colorectal, breast cancer diagnoses increase after start of COVID-19 pandemic; chemicals found in hair products increase viability of breast cancer cells in Black women; continued CDK 4/6 inhibition after breast cancer progression may benefit some patients; and more.
Read the full coverage here:
Late-stage colorectal, breast cancer diagnoses increase after start of COVID-19 pandemic
Chemicals found in hair products increase viability of breast cancer cells in Black women
Continued CDK 4/6 inhibition after breast cancer progression may benefit some patients
Some older women with luminal A breast cancer can safely forgo radiotherapy, study shows
Sacituzumab govitecan significantly extends PFS in advanced breast cancer subset
References:
Zhou JZ, et al. JAMA Netw Open. 2022;doi:10.1001/jamanetworkopen.2021.48581.
Trevino L, et al. RF22 | PMON05. Presented at: ENDO Annual Meeting; June 11-14, 2022; Atlanta (hybrid meeting).
Kalinsky K, et al. Abstract LBA1004. Presented at: ASCO Annual Meeting; June 3-7, 2022; Chicago.
Source: Whelan TJ, et al. Abstract LBA501. Presented at: ASCO Annual Meeting; June 3-7, 2022; Chicago.
Rugo HS, et al. Abstract LBA1001. Presented at: ASCO Annual Meeting; June 3-7, 2022; Chicago.
Collapse
Read more about
